Go Pro

Vertex Pharmaceuticals (VRTX) News Today

Vertex Pharmaceuticals logo
$483.27 -1.56 (-0.32%)
As of 01:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.

VRTX Latest News

VRTX Q2 Earnings Call Highlights Launch Momentum & Higher Outlook
CRISPR Therapeutics' Q2 Earnings & Revenues Surpass Estimates
How Vertex Regained Its Footing On A Competitor's Bullish Report
Vertex (VRTX) Buys Crinetics To Push Beyond Cystic Fibrosis
Vertex Pharmaceuticals (VRTX) Q2 2026
Vertex: Q2 Earnings Snapshot
Vertex Reports Second Quarter 2026 Financial Results
Vertex Raises 2026 Guidance, But Shares Dip For One Key Reason
Vertex Pharmaceuticals (VRTX) Q2 Earnings Lag Estimates
Vertex (VRTX) Reports Q2 Earnings: What Key Metrics Have to Say
Vertex Pharmaceuticals Q2 Earnings Call Highlights
Vertex Reports Second Quarter 2026 Financial Results
Vertex Pharmaceuticals (VRTX) to Post Earnings on Monday
Erste Group Bank Has Strong Outlook for VRTX FY2027 Earnings
Get Vertex Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VRTX Media Mentions By Week

VRTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VRTX
News Sentiment

0.83

0.62

Average
Healthcare
News Sentiment

VRTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VRTX Articles
This Week

55

10

VRTX Articles
Average Week

Get the Latest News and Ratings for VRTX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Vertex Pharmaceuticals and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:VRTX) was last updated on 8/6/2026 by MarketBeat.com Staff.
From Our Partners